Gilead’s $11.9 billion purchase of Kite Pharma in 2017 didn’t follow the script, with two big write-downs in the value of the asset since then, but a fresh approval for a CAR-T therapy could ...

That turned out to be one of the best pharma M&A deals of all time. But Gilead's hep C franchise peaked some time ago, and the firm needed another blockbuster to boost its prospects. Kite's lead ...

Story Jan. 10 - Shoreline Biosciences: The cell therapy biotech plans to let go of an undisclosed number of employees tied to a project with Gilead Sciences’ Kite Pharma. Story Jan. 9 - IGM ...

A notable potential in Russia and recovering Africa market further bolster optimism. India's pharma sector has seen remarkable growth in exports, with 99% target already being achieved before FY25, ...

Mankind Pharma Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 1,01,091.27 Crore) operating in Pharmaceuticals sector. Mankind Pharma Ltd. key Products/Revenue ...

IPC Indice de Precios Y Cotizaciones 52,817.75 142.96 0.27% ...

Whether you’re looking for a solo ride or a tandem adventure, kayaking is a fantastic way to soak in the sun and enjoy the tranquil surroundings of Kite Beach. Skaters and parkour enthusiasts will ...

8 February 2025 Marking World Cancer Day 2025, this week's Executive Q&A is with Diego Santoro, General Manager & Head of International Region at Gilead and Kite Oncology. Mr Santoro outlines the ...